Imaging of Prostate Cancer Using Two-Dimensional MR Spectroscopy and Diffusion Tensor Imaging
N/A
21 Years
80 Years
21 Years
80 Years
Not Enrolling
Male
Prostate Lesions
Male
Prostate Lesions
Trial Information
Imaging of Prostate Cancer Using Two-Dimensional MR Spectroscopy and Diffusion Tensor Imaging
Inclusion Criteria:
1. A male older than 21 years of age and under age of 80,
2. Either a normal healthy volunteer; a patient who has confirmed prostate cancer and
decided to receive prostatectomy; or a patient who has persistent elevated PSA higher
than 4.0 ng/ml, and with a prior benign biopsy scheduled to receive the second
biopsy.
Exclusion Criteria:
1. Unwilling to give informed consent,
2. Have implanted prosthetic heart valves, pacemaker, neuro-stimulation devices,
surgical clips (hemostatic clips) or other metallic implants,
3. Have engaged in occupations or activities which may cause accidental lodging of
ferromagnetic materials, or have imbedded metal fragments from military activities,
4. Have received orthodontic work involving ferromagnetic materials,
5. Claustrophobic,
6. Unable to lie down still for 60 minutes.
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
To demonstrate that multi-voxel MR spectroscopy and diffusion tensor imaging can accurately diagnose prostate cancer and benign diseases, also to provide an accurate disease extent.
Outcome Time Frame:
at completion of the study
Safety Issue:
No
Principal Investigator
Min-Ying Su, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of California, Irvine
Authority:
United States: Institutional Review Board
Study ID:
UCI-HS-2007-5671
NCT ID:
NCT00611065
Start Date:
June 2007
Completion Date:
Related Keywords:
- Prostate Lesions
- Prostatic Neoplasms
Name | Location |
|---|---|
| Center for Functional Onco-Imaging, University of California | Irvine, California 92697 |
